Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & Administrative
Others
Ratios

Pasithea Therapeutics (KTTA) Shares Outstanding (2021 - 2024)

Pasithea Therapeutics (KTTA) has disclosed Shares Outstanding for 4 consecutive years, with $1.0 million as the latest value for Q3 2024.

  • Quarterly Shares Outstanding changed 0.32% to $1.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Sep 2024, changed 0.32% year-over-year, with the annual reading at $1.0 million for FY2023, 20.0% down from the prior year.
  • Shares Outstanding hit $1.0 million in Q3 2024 for Pasithea Therapeutics, roughly flat from $1.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $26.5 million in Q2 2022 to a low of $1.0 million in Q3 2023.
  • Historically, Shares Outstanding has averaged $7.7 million across 4 years, with a median of $1.3 million in 2023.
  • Biggest five-year swings in Shares Outstanding: surged 221.48% in 2022 and later tumbled 96.08% in 2023.
  • Year by year, Shares Outstanding stood at $1.2 million in 2021, then rose by 13.19% to $1.3 million in 2022, then dropped by 20.0% to $1.0 million in 2023, then increased by 0.32% to $1.0 million in 2024.
  • Business Quant data shows Shares Outstanding for KTTA at $1.0 million in Q3 2024, $1.0 million in Q2 2024, and $1.0 million in Q1 2024.